Target Name: PLPP5
NCBI ID: G84513
Review Report on PLPP5 Target / Biomarker Content of Review Report on PLPP5 Target / Biomarker
PLPP5
Other Name(s): OTTHUMP00000228444 | Phosphatidic acid phosphatase type 2 domain-containing protein 1B | PLPP5 variant 2 | Phospholipid phosphatase 5, transcript variant 2 | phospholipid phosphatase 5 | OTTHUMP00000228422 | diacylglycerol pyrophosphate like 1 | PLPP5_HUMAN | Phospholipid phosphatase 5 | DPPL1 | phosphatidic acid phosphatase type 2 domain-containing protein 1B | HTPAP | testicular secretory protein Li 38 | diacylglycerol pyrophosphate phosphatase-like 1 | Phospholipid phosphatase 5 (isoform 2) | OTTHUMP00000228421 | Diacylglycerol pyrophosphate like 1 | OTTHUMP00000228419 | phosphatidate phosphatase PPAPDC1B | PPAPDC1B | OTTHUMP00000228423 | phosphatidic acid phosphatase type 2 domain containing 1B | OTTHUMP00000228420

PLPP5 Regulates TGF-β and P53 Activities

PLPP5 (poly (L-伪-glutamyl) peptide-5) is a protein that is expressed in various tissues and cells in the human body. It is a key regulator of cellular processes, including cell signaling, DNA replication, and chromatin structure. PLPP5 has also been shown to play a role in the development and progression of various diseases, including cancer.

One of the key functions of PLPP5 is its ability to interact with other proteins, including the oncogene transforming growth factor (TGF-β). TGF-β is a well-known protein that plays a critical role in the development and maintenance of tissues, including muscles, bones, and organs. It is also involved in the regulation of cell signaling, including the regulation of cell proliferation and differentiation.

PLPP5 has been shown to regulate the activity of TGF-β by interacting with its extracellular domain. This interaction between PLPP5 and TGF-β has important implications for the regulation of cellular processes, including the regulation of cell signaling and the regulation of cell proliferation.

In addition to its role in regulating TGF-β activity, PLPP5 has also been shown to play a role in the regulation of other proteins, including the transcription factor p53. p53 is a well-known protein that is involved in the regulation of cellular processes, including cell growth, apoptosis (programmed cell death), and DNA repair.

PLPP5 has been shown to regulate the activity of p53 by interacting with its amino-terminal region. This interaction between PLPP5 and p53 has important implications for the regulation of cellular processes, including the regulation of cell growth, apoptosis, and DNA repair.

In conclusion, PLPP5 is a protein that has important implications for the regulation of cellular processes, including cell signaling, DNA replication, and chromatin structure. Its interaction with TGF-β and p53 suggests that PLPP5 plays a critical role in the regulation of cellular processes, including the regulation of cell growth, apoptosis, and DNA repair. Further research is needed to fully understand the role of PLPP5 in cellular processes and its potential as a drug target or biomarker.

Protein Name: Phospholipid Phosphatase 5

Functions: Magnesium-independent phospholipid phosphatase with broad substrate specificity (PubMed:17590538). Preferentially catalyzes the conversion of diacylglycerol pyrophosphate into phosphatidate but can also act on phosphatidate and lysophosphatidate (PubMed:17590538). Phospholipid phosphatases are involved in both the synthesis of lipids and the generation or degradation of lipid-signaling molecules (PubMed:17590538)

The "PLPP5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLPP5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PLPP6 | PLPP7 | PLPPR1 | PLPPR2 | PLPPR3 | PLPPR4 | PLPPR5 | PLPPR5-AS1 | PLRG1 | PLS1 | PLS3 | PLSCR1 | PLSCR2 | PLSCR3 | PLSCR4 | PLSCR5 | PLTP | PLUT | PLVAP | PLXDC1 | PLXDC2 | PLXNA1 | PLXNA2 | PLXNA3 | PLXNA4 | PLXNB1 | PLXNB2 | PLXNB3 | PLXNC1 | PLXND1 | PM20D1 | PM20D2 | PMAIP1 | PMCH | PMCHL1 | PMCHL2 | PMEL | PMEPA1 | PMF1 | PMF1-BGLAP | PMFBP1 | PML | PMM1 | PMM2 | PMP2 | PMP22 | PMPCA | PMPCB | PMS1 | PMS2 | PMS2P1 | PMS2P12 | PMS2P13 | PMS2P2 | PMS2P3 | PMS2P4 | PMS2P5 | PMS2P9 | PMVK | PNCK | PNISR | PNISR-AS1 | PNKD | PNKP | PNKY | PNLDC1 | PNLIP | PNLIPRP1 | PNLIPRP2 | PNLIPRP3 | PNMA1 | PNMA2 | PNMA3 | PNMA5 | PNMA6A | PNMA8A | PNMA8B | PNMT | PNN | PNO1 | PNOC | PNP | PNPLA1 | PNPLA2 | PNPLA3 | PNPLA4 | PNPLA5 | PNPLA6 | PNPLA7 | PNPLA8 | PNPO | PNPT1 | PNRC1 | PNRC2 | POC1A | POC1B | POC1B-GALNT4 | POC5 | PODN | PODNL1